Tech
Irish-founded Shorla Oncology secures FDA approval for leukaemia drug
Company set up in 2018 has advanced pipeline of innovative oncology drugs for women's, orphan and paediatric cancers
Shorla Oncology, an Irish-founded healthcare start-up that develops pharmaceutical therapies to help cancer patients, has secured FDA approval to bring a speciality drug designed to treat T-cell leukaemia, to market in the United States.
The US Food and Drug Administration (FDA) has approved the use of the company’s oncology drug Nelarabine Injection for the treatment of leukaemia and lymphoblastic lymphoma.
Founded in 2018 by Sharon Cunningham and Orlaith Ryan, Shorla Oncology is a Clonmel, Tipperary ...